LCM Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
LCM Capital Management's LLY Position: Q2 2026 in Review
LCM Capital Management increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $27.6K and bringing the position to 245 shares worth $294K. The position accounts for 0.13% of the portfolio, ranked #87.
LCM Capital Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $369K in Q1 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- LCM Capital Management held 245 shares of Eli Lilly worth $294K as of Q2 2026.
- LCM Capital Management bought 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
- Eli Lilly made up 0.13% of LCM Capital Management's portfolio in Q2 2026, its #87 holding.
- LCM Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- LCM Capital Management's Eli Lilly position peaked at $369K in Q1 2025.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on LCM Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.